Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis

Pediatr Int. 2009 Oct;51(5):759-60. doi: 10.1111/j.1442-200X.2009.02935.x. Epub 2009 Aug 2.

Authors

Nobutada Tabata¹, Keisuke Sugimoto, Satoshi Ueda, Naoki Sakata, Mitsuru Okada, Toshiharu Miyake, Tohru Shinohara, Makoto Yagi, Takao Satou, Tsukasa Takemura

Affiliation

¹ Department of Pediatrics, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. batayann@star.so-net.jp

PMID: 19664011
DOI: 10.1111/j.1442-200X.2009.02935.x

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Child
Colitis, Ulcerative / drug therapy*
Female
Humans
Mesalamine / administration & dosage
Mesalamine / adverse effects*
Muscle, Skeletal / drug effects*
Muscle, Skeletal / pathology
Muscular Diseases / chemically induced*
Muscular Diseases / pathology
Wounds, Nonpenetrating / chemically induced
Wounds, Nonpenetrating / pathology

Substances

Anti-Inflammatory Agents, Non-Steroidal
Mesalamine